Literature DB >> 30202016

Host resistance to pulmonary Mycobacterium tuberculosis infection requires CD153 expression.

Michelle A Sallin1,2, Keith D Kauffman1, Catherine Riou3, Elsa Du Bruyn3, Taylor W Foreman1, Shunsuke Sakai1, Stella G Hoft1, Timothy G Myers4, Paul J Gardina4, Alan Sher5, Rashida Moore6, Temeri Wilder-Kofie6, Ian N Moore6, Alessandro Sette7,8, Cecilia S Lindestam Arlehamn8, Robert J Wilkinson3,9,10, Daniel L Barber11.   

Abstract

Mycobacterium tuberculosis infection (Mtb) is the leading cause of death due to a single infectious agent and is among the top ten causes of all human deaths worldwide1. CD4 T cells are essential for resistance to Mtb infection, and for decades it has been thought that IFNγ production is the primary mechanism of CD4 T-cell-mediated protection2,3. However, IFNγ responses do not correlate with host protection, and several reports demonstrate that additional anti-tuberculosis CD4 T-cell effector functions remain unaccounted for4-8. Here we show that the tumour-necrosis factor (TNF) superfamily molecule CD153 (encoded by the gene Tnfsf8) is required for control of pulmonary Mtb infection by CD4 T cells. In Mtb-infected mice, CD153 expression is highest on Mtb-specific T helper 1 (TH1) cells in the lung tissue parenchyma, but its induction does not require TH1 cell polarization. CD153-deficient mice develop high pulmonary bacterial loads and succumb early to Mtb infection. Reconstitution of T-cell-deficient hosts with either Tnfsf8-/- or Ifng-/- CD4 T cells alone fails to rescue mice from early mortality, but reconstitution with a mixture of Tnfsf8-/- and Ifng-/- CD4 T cells provides similar protection as wild-type T cells. In Mtb-infected non-human primates, CD153 expression is much higher on Ag-specific CD4 T cells in the airways compared to blood, and the frequency of Mtb-specific CD153-expressing CD4 T cells inversely correlates with bacterial loads in granulomas. In Mtb-infected humans, CD153 defines a subset of highly polyfunctional Mtb-specific CD4 T cells that are much more abundant in individuals with controlled latent Mtb infection compared to those with active tuberculosis. In all three species, Mtb-specific CD8 T cells did not upregulate CD153 following peptide stimulation. Thus, CD153 is a major immune mediator of host protection against pulmonary Mtb infection and CD4 T cells are one important source of this molecule.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30202016     DOI: 10.1038/s41564-018-0231-6

Source DB:  PubMed          Journal:  Nat Microbiol        ISSN: 2058-5276            Impact factor:   17.745


  22 in total

1.  Strategies for Targeting Senescent Cells in Human Disease.

Authors:  Nathan S Gasek; George A Kuchel; James L Kirkland; Ming Xu
Journal:  Nat Aging       Date:  2021-10-07

2.  Mucosal Vaccination with Cyclic Dinucleotide Adjuvants Induces Effective T Cell Homing and IL-17-Dependent Protection against Mycobacterium tuberculosis Infection.

Authors:  Robyn M Jong; Erik Van Dis; Samuel B Berry; Xammy Nguyenla; Alexander Baltodano; Gabrielle Pastenkos; Chenling Xu; Douglas Fox; Nir Yosef; Sarah M McWhirter; Sarah A Stanley
Journal:  J Immunol       Date:  2021-12-29       Impact factor: 5.422

Review 3.  Archetypes of checkpoint-responsive immunity.

Authors:  Kwok Im; Alexis J Combes; Matthew H Spitzer; Ansuman T Satpathy; Matthew F Krummel
Journal:  Trends Immunol       Date:  2021-10-09       Impact factor: 16.687

4.  Ultrasound-Based Radiomics Can Classify the Etiology of Cervical Lymphadenopathy: A Multi-Center Retrospective Study.

Authors:  Yajing Liu; Jifan Chen; Chao Zhang; Qunying Li; Hang Zhou; Yiqing Zeng; Ying Zhang; Jia Li; Wen Xv; Wencun Li; Jianing Zhu; Yanan Zhao; Qin Chen; Yi Huang; Hongming Li; Ying Huang; Gaoyi Yang; Pintong Huang
Journal:  Front Oncol       Date:  2022-05-17       Impact factor: 5.738

Review 5.  Tuberculosis Vaccine Development: Progress in Clinical Evaluation.

Authors:  Suraj B Sable; James E Posey; Thomas J Scriba
Journal:  Clin Microbiol Rev       Date:  2019-10-30       Impact factor: 26.132

Review 6.  Moving tuberculosis vaccines from theory to practice.

Authors:  Peter Andersen; Thomas J Scriba
Journal:  Nat Rev Immunol       Date:  2019-09       Impact factor: 53.106

7.  A virtual host model of Mycobacterium tuberculosis infection identifies early immune events as predictive of infection outcomes.

Authors:  Louis R Joslyn; Jennifer J Linderman; Denise E Kirschner
Journal:  J Theor Biol       Date:  2022-01-31       Impact factor: 2.405

8.  Functionally Overlapping Variants Control Tuberculosis Susceptibility in Collaborative Cross Mice.

Authors:  Clare M Smith; Megan K Proulx; Rocky Lai; Michael C Kiritsy; Timothy A Bell; Pablo Hock; Fernando Pardo-Manuel de Villena; Martin T Ferris; Richard E Baker; Samuel M Behar; Christopher M Sassetti
Journal:  mBio       Date:  2019-11-26       Impact factor: 7.867

9.  Enhancement of CD4+ T Cell Function as a Strategy for Improving Antibiotic Therapy Efficacy in Tuberculosis: Does It Work?

Authors:  Diego L Costa; Eduardo P Amaral; Sivaranjani Namasivayam; Lara R Mittereder; Bruno B Andrade; Alan Sher
Journal:  Front Cell Infect Microbiol       Date:  2021-06-21       Impact factor: 5.293

Review 10.  Targeting Unconventional Host Components for Vaccination-Induced Protection Against TB.

Authors:  Elisa Nemes; Shabaana A Khader; Rosemary V Swanson; Willem A Hanekom
Journal:  Front Immunol       Date:  2020-07-24       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.